Patents by Inventor Randi Albin

Randi Albin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NMDA RECEPTOR ANTAGONIST FORMULATION WITH REDUCED NEUROTOXICITY
    Publication number: 20140171514
    Abstract: The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and preservative for the administration to a patient in need of effective analgesia and anesthesia. The compositions of the invention advantageously do not cause any significant neurotoxicity. The preferred NMDA receptor antagonist is ketamine. The preferred preservative is benzalkonium chloride.
    Type: Application
    Filed: February 21, 2014
    Publication date: June 19, 2014
    Applicant: Stuart L. Weg
    Inventors: Fred H. Mermelstein, Randi Albin
  • NMDA Receptor Antagonist Formulation With Reduced Neurotoxicity
    Publication number: 20080041367
    Abstract: The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and preservative for the administration to a patient in need of effective analgesia and anesthesia. The compositions of the invention advantageously do not cause any significant neurotoxicity. The preferred NMDA receptor antagonist is ketamine. The preferred preservative is benzalkonium chloride.
    Type: Application
    Filed: August 16, 2007
    Publication date: February 21, 2008
    Inventors: Fred Mermelstein, Randi Albin
  • NMDA receptor antagonist formulation with reduced neurotoxicity
    Patent number: 7273889
    Abstract: The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and preservative for the administration to a patient in need of effective analgesia and anesthesia. The compositions of the invention advantageously do not cause any significant neurotoxicity. The preferred NMDA receptor antagonist is ketamine. The preferred preservative is benzalkonium chloride.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: September 25, 2007
    Assignee: Innovative Drug Delivery Systems, Inc.
    Inventors: Fred H. Mermelstein, Randi Albin
  • NMDA receptor antagonist formulation with reduced neurotoxicity
    Publication number: 20040138298
    Abstract: The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and non-neurotoxic compounds having preservative activity for the administration to a patient in need of effective analgesia and anesthesia. The compositions of the invention advantageously do not cause any significant neurotoxicity. The preferred NMDA receptor antagonist is ketamine. The non-neurotoxic compound is selected from one of the following groups including organic acids, esters thereof, and salts thereof; alcohols, polyols, and phenols; alkyl parabens; cresols; benzalkonium chloride quaternary ammonium salts; chlorhexidine, imidurea, alpha tocopherol, and EDTA. Preferably, the nonneurotoxic compound is benzalkonium chloride, benzyl alcohol or phenol.
    Type: Application
    Filed: December 5, 2003
    Publication date: July 15, 2004
    Applicant: Innovative Drug Delivery Systems, Inc.
    Inventors: Fred H. Mermelstein, Randi Albin
  • NMDA receptor antagonist formulation with reduced neurotoxicity
    Publication number: 20040059003
    Abstract: The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and preservative for the administration to a patient in need of effective analgesia and anesthesia. The compositions of the invention advantageously do not cause any significant neurotoxicity. The preferred NMDA receptor antagonist is ketamine. The preferred preservative is benzalkonium chloride.
    Type: Application
    Filed: September 25, 2002
    Publication date: March 25, 2004
    Applicant: Innovative Drug Delivery Systems, Inc.
    Inventors: Fred H. Mermelstein, Randi Albin